{"id":"W3201611853","doi":"10.1136/jitc-2021-003122","title":"Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Ovarian Cancer Academy; Merck Sharp and Dohme; U.S. Department of Defense","keywords":"Carboplatin; Medicine; Ovarian cancer; Pembrolizumab; Fallopian tube cancer; Oncology; Fallopian tube; Internal medicine; Gynecology; Cancer; Chemotherapy; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006805173,0.0002793308,0.0005958712,0.000146578,0.0001866245,0.0001990235,0.0002243203,0.0003164674,0.0008890539],"category_scores_gemma":[0.0006667071,0.00009851845,0.0003050754,0.0001472232,0.0002027268,0.000182099,0.000138052,0.0005559903,0.0001246239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004366054,"about_ca_system_score_gemma":0.0003425688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004135577,"about_ca_topic_score_gemma":0.001156959,"domain_scores_codex":[0.9998341,0.00008110364,0.00001519892,0.0000227105,0.00002272222,0.00002410785],"domain_scores_gemma":[0.9997483,0.00007992395,0.00006294157,0.00001611004,0.00001315641,0.00007965717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1654711,0.01331096,0.1399343,0.001508261,0.001464712,0.002216274,0.0003447921,0.002679663,0.09161623,0.0002179197,0.003265959,0.5779698],"study_design_scores_gemma":[0.07327981,0.340845,0.5361986,0.0002221654,0.001268537,0.009380913,0.000120706,0.006274184,0.02322139,0.000237831,0.008915963,0.00003481212],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955276,0.003534694,0.0001514509,0.00009907283,0.00001423858,0.0001255113,0.00004682735,0.00001107677,0.0004895084],"genre_scores_gemma":[0.9985644,0.0006624141,0.0002281161,0.00009152877,0.00003049349,0.00008533689,0.0001174876,0.000001550192,0.0002187178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008890539,"threshold_uncertainty_score":0.003598988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01718030431608468,"score_gpt":0.3050659985256309,"score_spread":0.2878856942095462,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}